Propel Bio Management, LLC / OVID
Propel Bio Management, LLC’s Ovid Therapeutics Inc Position
Does Propel Bio Management, LLC own Ovid Therapeutics Inc (OVID)? Yes — 921.5K shares worth $2M (+1.28% of its 13F portfolio) as of Q1 2026.
Position Value
$2M
Q1 2026
Shares
921.5K
% of Portfolio
+1.28%
Quarters Held
1
currently held
Position History OVID
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 921.5K | $2M | +1.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of OVID.